For countless families touched by Huntington’s disease (HD), a genetic neurodegenerative disorder with no cure or disease-modifying treatments, the struggle against an inevitable decline has been a heartbreaking reality, but a beacon of hope emerged on September 24, 2025. On that date, uniQure
Imagine a seemingly healthy individual suddenly struck by a series of unexplained strokes, only to discover that these alarming events are not tied to typical heart issues but to a silent, deadly malignancy lurking within, such as colorectal cancer. This scenario, far from mere speculation,
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose deep knowledge of technology and innovation in the industry has positioned him as a leading voice in research and development. Today, we’re diving into the fascinating study of Maria Branyas Morera, who lived to the
Imagine a world where a devastating, inherited brain disorder that robs individuals of their ability to move, think, and live independently could be slowed dramatically with a single medical intervention. Huntington's disease, a fatal neurodegenerative condition caused by a defect in the HTT gene,
Pancreatic cancer remains one of the most devastating diagnoses a patient can receive, with survival rates that have barely improved in decades and a prognosis that often leaves little room for hope. Among the various forms of this disease, pancreatic ductal adenocarcinoma (PDAC) stands out as the
Imagine a condition so rare yet so devastating that it drives an insatiable hunger, challenging both patients and medical science to find relief, while Prader-Willi syndrome, a genetic disorder affecting a small but deeply impacted population, has long awaited effective treatments for its hallmark
